View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Brentuximab Vedotin 1.8, cutaneous T-cell lymphoma
Protocol-ID: 1389 V1.0 (Mini), BRNT1.8, CTCLIndication(s)
- NHL, T-Cell Type, Cutaneous Primary, CD30-Positive; ICD-10 C86.6
- NHL, T-Cell Type, Cutaneous, Unspecified (CD30+); ICD-10 C84.8
- NHL, T-Cell Type, Mycosis Fungoides; ICD-10 C84.0
- NHL, T-Cell Type, Sézary Syndrome; ICD-10 C84.1
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 17.10.2019